Decrease in the incidence of acute myocardial ischemic syndrome in young women has slowed
31.12.2024 10:33:02 EET | HUS | Press release
Finland has not succeeded in reducing the incidence of acute myocardial ischemic syndrome in young and middle-aged women. The number of cases among older women and men decreased every year until the 2010s, but this decline has now stagnated. However, there has been a reduction in the mortality rate. Attention should still be paid to the prevention of cardiovascular diseases.

The Heart and Lung Center and the Finnish Institute for Health and Welfare (THL) have studied the trends in acute myocardial ischemic syndrome in women and men aged 35–74 in 1996–2021. Researchers examined the trends in incidence, mortality and case fatality.
“There was an annual reduction of approximately 1.7% in the incidence of acute myocardial ischemic syndrome in women aged 35–74, but this decline started to stagnate at the beginning of the 2010s. There was no change in the incidence among young and middle-aged women aged 35–55 during the study period,” says Licentiate of Medicine Atte Kallström.
In men, the incidence of acute myocardial ischemic syndrome decreased in all age groups, but the decline started to slow down at the beginning of the 2010s. On average, the incidence decreased by 2.0% annually.
“We have not succeeded in preventing acute myocardial ischemic syndrome in particular in young women in the 21st century, despite education and new medications. In order for the decline in incidence to continue to go down among older women and men of all ages, more attention should also be paid to prevention,” emphasizes Doctor of Medical Science Markus Ramste from the Heart and Lung Center.
People can identify the symptoms of heart attack and seek medical attention
The decrease in mortality was much faster than the decrease in incidence and remained stable throughout the period studied. On average, mortality decreased by 4.4% among men and 5.0% among women each year. On average, case fatality decreased by 2.7% among men and 3.3% among women each year.
The decrease in mortality is likely a result of improved treatment practices for acute myocardial ischemic syndrome and the fact that people are more aware of the importance of seeking medical attention if they experience heart attack symptoms.
The widespread adoption of accurate blood tests in health care may also be the reason why more “minor” heart attacks are now more easily detected, impacting the decline in mortality and case fatality.
“Mortality has been declining for a long time and there has also been a decline in incidence, but we can achieve better outcomes. In many Western European countries, the mortality rate of cardiovascular diseases is lower than in Finland,” says Professor Juha Sinisalo from the Heart and Lung Center.
Link to the study:
Full article: Divergent trends in the incidence and mortality of acute myocardial ischaemic syndrome, especially in women. Evidence from Finland in 1996–2021
In a university hospital, research is part of the treatment: we continuously evaluate and develop care based on scientific research evidence and patient experience. At HUS, we conduct close research collaboration with the Faculty of Medicine at the University of Helsinki. We publish approximately 2,400 peer-reviewed research articles) annually, which we highlight in our newsfeed.
About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
HUS-sammanslutningens styrelse sammanträder den 20 april 202616.4.2026 15:10:51 EEST | Pressmeddelande
HUS-sammanslutningens styrelse sammanträder måndagen den 20 april 2026 för att behandla bland annat förslaget till budget för 2027 samt verksamheten och ekonomin för januari–februari 2026. Föredragningslistan för mötet finns här. HUS medietjänst betjänar medier måndag–torsdag kl. 10–16, fredag kl. 10–15 på numret 050 427 2875 eller per e-post på viestinta@hus.fi. Se avvikande öppettider.
HUSin yhtymähallitus kokoontuu 20.4.202616.4.2026 15:10:51 EEST | Tiedote
HUSin yhtymähallitus kokoontuu maanantaina 20.4.2026 käsittelemään muun muassa talousarvioesitystä vuodelle 2027 sekä tammi-helmikuun 2026 toimintaa ja taloutta. Kokouksen esityslistan pääset lukemaan täältä. HUSin mediapalvelu palvelee mediaa ma–to klo 10–16, pe klo 10–15 numerossa 050 427 2875 tai sähköpostitse viestinta@hus.fi. Katso poikkeusaukioloajat
Kolesterol som tas upp från tarmen kan öka risken för allvarliga hjärthändelser15.4.2026 08:00:04 EEST | Pressmeddelande
Enbart mängden LDL-kolesterol anger inte om en människa kommer att drabbas av en hjärtsjukdom. Hos en del människor tas kolesterol upp ytterst effektivt från tarmen. Det kan öka risken för allvarliga hjärthändelser, även om det inte visar sig i blodets kolesterolvärden, vilket framgår av Helsingfors universitets och HUS färska studie.
Suolistosta imeytyvä kolesteroli voi lisätä vakavien sydäntapahtumien riskiä15.4.2026 08:00:04 EEST | Tiedote
Pelkkä LDL-kolesterolin määrä ei kerro sitä, sairastuuko ihminen sydänsairauteen. Osalla ihmisistä kolesteroli imeytyy erityisen tehokkaasti suolistosta. Se voi lisätä vakavien sydäntapahtumien riskiä, vaikkei sitä huomaisi veren kolesteroliarvoista. Asia selviää Helsingin yliopiston ja HUSin tuoreesta tutkimuksesta.
Jorvs sjukhus nya huvudingång öppnas den 20 april 202614.4.2026 14:14:53 EEST | Pressmeddelande
Från och med måndagen den 20 april anländer man dagtid till Jorvs sjukhus via den nya huvudingången. Den nya ingången är belägen i avdelningsbyggnaden som färdigställdes i januari och genom vilken man också går till Jorvs gamla sjukhusbyggnad. I detta skede tas endast huvudingången och huvudentréhallen i bruk i nybyggnaden. Ändringen gäller inte föderskor och personer som kommer till jouren.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom